4-Week, Multi-center Dose-Ranging Study for the IBS-C in Pts. 6 to <12 Yrs

Clinical trial NCT06553547 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT06553547
Sponsor: Ardelyx
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Irritable Bowel Syndrome With Constipation (IBS-C)

Start date: 2024-07-24
Primary completion: 2026-07-01
Enrollment: 72

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.